MT189
CAS No. 1885900-35-5
MT189 ( —— )
产品货号. M35337 CAS No. 1885900-35-5
Antiproliferative agent-14 (compound 3b) 是一种有效的微管蛋白聚合 (tubulin polymerization) 抑制剂,IC50 为 3.41 μM。Antiproliferative agent-14 具有优异的抗增殖活性。Antiproliferative agent-14 具有在细胞周期的 G2/M 期阻滞细胞的能力。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥503 | 有现货 |
|
| 10MG | ¥787 | 有现货 |
|
| 25MG | ¥1293 | 有现货 |
|
| 50MG | ¥1860 | 有现货 |
|
| 100MG | ¥2529 | 有现货 |
|
| 200MG | ¥3483 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称MT189
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Antiproliferative agent-14 (compound 3b) 是一种有效的微管蛋白聚合 (tubulin polymerization) 抑制剂,IC50 为 3.41 μM。Antiproliferative agent-14 具有优异的抗增殖活性。Antiproliferative agent-14 具有在细胞周期的 G2/M 期阻滞细胞的能力。
-
产品描述Antiproliferative agent-14 (compound 3b) a potent tubulin polymerization inhibitor, with an IC50 of 3.41 μM. Antiproliferative agent-14 has excellent antiproliferative activity. Antiproliferative agent-14 possess the ability to arrest cells at G2/M phases of the cell cycle.
-
体外实验Antiproliferative agent-14 (compound 3b) shows antiproliferative activity against HeLa cell (IC50=13 nM).Antiproliferative agent-14 shows inhibition of colchicine binding activity, with 72.2% inhibitory percentage.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Microtubule Associated
-
研究领域——
-
适应症——
化学信息
-
CAS Number1885900-35-5
-
分子量363.38
-
分子式C21H18FN3O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : ≥ 100 mg/mL (275.19 mM )
-
SMILESCOc1ccc(CNc2c(nc3ccc(F)cn23)-c2ccccc2O)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. An W, et al. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents. Eur J Med Chem. 2016 Apr 13;112:367-372. ?
产品手册
关联产品
-
γ-Glu-Phe TFA(7432-2...
γ-Glu-Phe TFA (γ-Glutamylphenylalanine TFA) is synthesized from bacillus amyloliquefaciens (GBA) and aspergillus oryzae (GAO).
-
p60c-src Substrate I
p60c-src Substrate 是一种高效特异性的 p60c-src 蛋白酪氨酸激酶 (PTK) 的底物。p60c-src Substrate 可用于合成嵌合支化多肽。
-
LEM-14-1189 B
Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively. LEM-14-1189 has potential anticancer activity and can be used to study multiple myeloma (MM) and diseases of the blood system.
021-51111890
购物车()
sales@molnova.cn

